Emergent BioSolutions to Release Third Quarter 2012 Financial Results and Conduct a Conference Call

Before you go, we thought you'd like these...
Before you go close icon

Emergent BioSolutions to Release Third Quarter 2012 Financial Results and Conduct a Conference Call on November 1, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)-- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it will report financial results for the third quarter 2012 on Thursday, November 1, 2012, before market open.

Company management will host a conference call at 8:00 AM Eastern on November 1, 2012 to discuss the financial results for the third quarter and first nine months of 2012, recent business developments, revenue guidance for the fourth quarter of 2012 and revenue and net income guidance for full year 2012. The conference call will be accessible by dialing 888/679-8037 or 617/213-4849 (international) and providing passcode 34805828. A webcast of the conference call will be accessible from the company's website at www.emergentbiosolutions.com, under "Investors".


Emergent BioSolutions is offering call participants a pre-registration option that expedites access to the call and minimizes hold times. Pre-registrants will be issued a pin number to be used when dialing into the live call which will provide quick access to the conference call by bypassing the operator upon connection. Pre-registration, while not mandatory, can be accessed using the following website: https://www.theconferencingservice.com/prereg/key.process?key=PP8VBC7JJ

A replay of the conference call will be accessible, approximately two hours following the conclusion of the call, by dialing 888/286-8010 or 617/801-6888 and using the passcode 51609046. The replay will be available through November 8, 2012. The webcast will be archived on the company's website, www.emergentbiosolutions.com, under "Investors".

About Emergent BioSolutions Inc.

Emergent BioSolutions protects and enhances life by developing and manufacturing vaccines and therapeutics that are supplied to healthcare providers and purchasers for use in preventing and treating disease. Emergent's marketed and investigational products target infectious diseases, oncology and autoimmune disorders. Additional information about the company may be found at www.emergentbiosolutions.com.

Follow us on Twitter: @emergentbiosolu



Emergent BioSolutions Inc.
Investors Contact:
Robert G. Burrows
Vice President, Investor Relations
301-795-1877
BurrowsR@ebsi.com
or
Media Contact:
Tracey Schmitt
Vice President, Corporate Communications
301-795-1800
SchmittT@ebsi.com

KEYWORDS:   United States  North America  Maryland

INDUSTRY KEYWORDS:

The article Emergent BioSolutions to Release Third Quarter 2012 Financial Results and Conduct a Conference Call on November 1, 2012 originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners